Clinical Trial Update: Huachansu & Gemcitabine in Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Huachansu in combination with gemcitabine for pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Huachansu

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED